PL354990A1 - Białka HCV o konfrontacji typu natywnego z odwracalnym układem redox - Google Patents

Białka HCV o konfrontacji typu natywnego z odwracalnym układem redox

Info

Publication number
PL354990A1
PL354990A1 PL00354990A PL35499000A PL354990A1 PL 354990 A1 PL354990 A1 PL 354990A1 PL 00354990 A PL00354990 A PL 00354990A PL 35499000 A PL35499000 A PL 35499000A PL 354990 A1 PL354990 A1 PL 354990A1
Authority
PL
Poland
Prior art keywords
native
redox system
reversible redox
hcv proteins
type confrontation
Prior art date
Application number
PL00354990A
Other languages
English (en)
Polish (pl)
Inventor
Alfons Bosman
Erik Depla
Geert Maertens
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of PL354990A1 publication Critical patent/PL354990A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL00354990A 1999-10-27 2000-10-25 Białka HCV o konfrontacji typu natywnego z odwracalnym układem redox PL354990A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870225 1999-10-27
US16928899P 1999-12-07 1999-12-07
PCT/EP2000/010499 WO2001030815A1 (en) 1999-10-27 2000-10-25 Redox reversible hcv proteins with native-like conformation

Publications (1)

Publication Number Publication Date
PL354990A1 true PL354990A1 (pl) 2004-03-22

Family

ID=30129297

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354990A PL354990A1 (pl) 1999-10-27 2000-10-25 Białka HCV o konfrontacji typu natywnego z odwracalnym układem redox

Country Status (14)

Country Link
EP (1) EP1224214A1 (cs)
JP (1) JP2003513022A (cs)
CN (1) CN1384839A (cs)
AU (1) AU1144501A (cs)
BR (1) BR0015170A (cs)
CA (1) CA2387666A1 (cs)
CZ (1) CZ20021819A3 (cs)
HU (1) HUP0203195A3 (cs)
MX (1) MXPA02004052A (cs)
NZ (1) NZ518095A (cs)
PL (1) PL354990A1 (cs)
RU (1) RU2002109480A (cs)
WO (1) WO2001030815A1 (cs)
ZA (1) ZA200203169B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001273348A1 (en) 2000-07-10 2002-01-21 Diosynth Rtp, Inc. Purification of human troponin i
CN1636050A (zh) 2001-04-24 2005-07-06 基因创新有限公司 核心糖基化hcv包膜蛋白
EP1481984A1 (en) * 2003-05-28 2004-12-01 Innogenetics N.V. Modified hepatitis C virus (HCV) NS5
JP2016512241A (ja) * 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
EP3756648A1 (en) * 2019-06-27 2020-12-30 Imnate Sarl Improved vaccine formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
AU652919B2 (en) * 1989-06-02 1994-09-15 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
ES2174957T5 (es) * 1994-07-29 2006-12-16 Innogenetics N.V. Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
GB9703406D0 (en) * 1997-02-19 1997-04-09 Chiron Spa Expression of heterologous proteins
EP0947525A1 (en) * 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue

Also Published As

Publication number Publication date
JP2003513022A (ja) 2003-04-08
CA2387666A1 (en) 2001-05-03
NZ518095A (en) 2003-09-26
AU1144501A (en) 2001-05-08
BR0015170A (pt) 2002-06-25
ZA200203169B (en) 2003-09-23
RU2002109480A (ru) 2004-03-10
HUP0203195A2 (hu) 2002-12-28
CZ20021819A3 (cs) 2003-06-18
HUP0203195A3 (en) 2004-07-28
WO2001030815A1 (en) 2001-05-03
EP1224214A1 (en) 2002-07-24
CN1384839A (zh) 2002-12-11
MXPA02004052A (es) 2002-11-07

Similar Documents

Publication Publication Date Title
DE69928342D1 (de) Miniaturpositionsfühler
DE69942895D1 (de) Replikons exprimierte ebola virion-proteine
IS6040A (is) Valdekoxib efnablöndur
DE69938221D1 (de) Positionssensor
DK1147121T3 (da) Ketolidantibiotika
DE69934776D1 (de) Positionssensor
DE60012691D1 (de) Diffusoreinheit
DE50015835D1 (de) Sensor
NO20003916D0 (no) Benzotiadiazoler og derivater
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
DE59809734D1 (de) Wegsensor
DE60002531D1 (de) Kleinkultiviergerät
DE50009018D1 (de) Positionssensor
NO20015916D0 (no) Lavströms sensor
DE59908817D1 (de) Wässrige zubereitungen
NO991000D0 (no) Sensorelement
PL354990A1 (pl) Białka HCV o konfrontacji typu natywnego z odwracalnym układem redox
DE59903380D1 (de) Etikettensensor
DK1051156T3 (da) Farmaceutiske præparater
ID25990A (id) Susunan dna
DE60019667D1 (de) Silberhalogenidemulsion
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid
DE60033215D1 (de) Farbband
ID22308A (id) Kerangka elektromotor
DE50009295D1 (de) Vernetzerfreie zubereitungen

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)